Bharat Rasayan Limited (NSE: BHARATRAS)
Source: Bharat Rasayan Limited Annual Report FY 2025-26 (Fiscal Year Ended March 31, 2026) 📊 Stock Screeners
Bharat Rasayan Limited (BRL) operates as a premier Indian agrochemical manufacturing entity specializing in high-grade Technical Grade Pesticides and chemical intermediates. Incorporated in 1989 as a strategic backward-integration venture within the Bharat Group, the company manufactures generic and niche active ingredients confirming to rigorous international standards.
- Insecticides: Technical grade active ingredients targeting chewing and sucking pests across foodgrains, cotton, and commercial crops.
- Herbicides: Soil-active and foliar synthetic herbicides engineered to manage weeds, preserving crop nutrients and enhancing land productivity.
- Fungicides & Plant Growth Regulators: Speciality crop protection compounds designed to control fungal pathogens and enhance yields.
- Chemical Intermediates: Advanced organic building blocks synthesized for internal technical production and specialized business partners.
📋 Quick Facts / Company Snapshot: Bharat Rasayan Limited (NSE: BHARATRAS)
| Attribute | Disclosed Detail |
|---|---|
| Official Company Name | Bharat Rasayan Limited |
| Corporate Identity Number (CIN) | L24119DL1989PLC036264 |
| ISIN | INE838B01021 |
| Stock Exchange Listing | National Stock Exchange of India Limited (NSE: BHARATRAS) |
| Date of Incorporation / Founding Year | May 15, 1989 |
| Founders / Key Founding Figures | Shri Sat Narain Gupta, Shri Mahabir Prasad Gupta, Shri Rajender Prasad Gupta |
| Registered Office & Corporate Headquarters | 1501, Vikram Tower, Rajendra Place, New Delhi – 110 008, India |
| Telephone & Official IR Email | +91-11-43661111 | investors.brl@bharatgroup.co.in |
| Chairman & Managing Director | Shri Sat Narain Gupta (Chairman & Managing Director) |
| Chief Financial Officer (CFO) & Company Secretary (CS) | Shri Rakesh Verma (CFO) | Ms. Nikita Chadha (Company Secretary) |
| Promoter & Holding Group | Bharat Group / Gupta Family & Associate Entities |
| Industry / Sector Classification | Agrochemicals / Technical Grade Pesticides & Intermediates (NIC: 20211, 20299) |
| Workforce Count & Turnover Rate | 1,571 Total Workforce (903 Permanent Employees, 668 Contractual Workers) | Employee Turnover Rate: 35.49% |
| Manufacturing Plants / Facilities Count | 3 Manufacturing Facilities (Unit-I Mokhra, Haryana; Unit-II Dahej, Gujarat; Unit-III Dahej-3, Gujarat) |
| Credit Ratings & Rating Agency | CARE Ratings: CARE AA- (Long Term Facilities) | CARE A1+ (Short Term Facilities) |
| Statutory, Secretarial & Cost Auditors | Statutory: M/s. B.K. Goel & Associates | Secretarial: M/s A. Anand & Co. | Cost: M/s. M.K. Singhal & Co. |
| Registrar & Share Transfer Agent (RTA) | M/s. MUFG Intime India Pvt. Limited (Janakpuri, New Delhi) |
🏢 The Corporate Identity: Bharat Rasayan Overview, Promoters & History
The Big Picture: Business Model & Core Value Proposition
Bharat Rasayan Limited (BRL) operates as a premier Indian agrochemical manufacturing entity specializing in high-grade Technical Grade Pesticides and chemical intermediates. Incorporated in 1989 as a strategic backward-integration venture within the Bharat Group, the company manufactures generic and niche active ingredients confirming to rigorous international standards. BRL caters to leading domestic crop protection brands as well as global multinational agrochemical corporations across international markets.
The company’s underlying business model relies on maintaining fully integrated chemical manufacturing infrastructures, strong internal Research & Development capabilities, and strategic international partnerships. By developing cost-effective synthesis routes for complex active molecules—spanning insecticides, herbicides, fungicides, and plant growth regulators—Bharat Rasayan bridges the gap between raw chemical intermediates and final formulations. The company functions as both an independent technical-grade manufacturer and a trusted contract manufacturing partner for global crop protection giants.
The Founders, Promoters & Their Legacy
The operational and strategic foundation of Bharat Rasayan was laid by the Gupta family under the stewardship of Shri Sat Narain Gupta, Shri Mahabir Prasad Gupta, and Shri Rajender Prasad Gupta. Over three and a half decades, the promoter family transformed BRL from a basic chemical unit into a technology-driven manufacturing enterprise listed on the National Stock Exchange of India.
The executive execution is spearheaded by Shri Sat Narain Gupta (Chairman & Managing Director), alongside Executive Directors Shri Ajay Gupta and Shri Kamleshwar Prasad Uniyal. The promoter group actively maintains strong administrative and operational control, holding a collective equity stake of 74.99% as of March 31, 2026. The succession framework incorporates second-generation leadership, including the appointment of Shri Vikas Gupta as Non-Executive & Non-Independent Director to oversee operations, capital allocation, and group synergies.
The Journey: Corporate History & Key Milestones
Bharat Rasayan’s commercial evolution is defined by strategic manufacturing expansions, technology investments, and international joint ventures:
- 1989: Incorporation of Bharat Rasayan Limited on May 15, 1989, initiating a backward integration vision for technical-grade pesticides.
- Unit-I Establishment (Mokhra, Haryana): Commissioning of the primary technical synthesis plant at Rohtak district, focusing on conventional insecticide and herbicide molecules.
- Unit-II Expansion (Dahej, Gujarat): Strategic expansion into the GIDC Industrial Estate at Dahej, establishing large-scale chemical multi-product plants catering to domestic and export demand.
- 2020 (Nissan Chemical JV): Formation of a landmark 30:70 Joint Venture agreement on February 18, 2020, with Japan’s Nissan Chemical Corporation to establish Nissan Bharat Rasayan Private Limited for greenfield active ingredient manufacturing.
- 2021 (Unit-III Greenfield Plot): Acquisition of industrial land at Plot No. D-3/21/2/1, Dahej-3, Gujarat, for future multi-purpose plant additions.
- FY 2025-26: Share sub-division (split from face value ₹10 to ₹5) and 1:1 Bonus Issue, expanding total equity share base to 1,66,21,072 shares. Inauguration of the Science & NewGen Research Centre at Bahadurgarh on March 11, 2026.
The Corporate Umbrella & Group Structure
Bharat Rasayan Limited serves as the flagship listed entity of the broader Bharat Group. While BRL operates independently with its manufacturing units, it retains key operational synergies with promoter-controlled entities such as B R Agrotech Limited, Bharat Certis Agriscience Limited, and BRL Finlease Limited. Additionally, BRL holds a strategic 30% equity stake in Nissan Bharat Rasayan Private Limited, its primary joint venture with Japan’s Nissan Chemical Corporation.
⚙️ The Business Engine: Bharat Rasayan Segments, Brands, Products & Operations
The Core Divisions & Segment Revenue Breakdown
In accordance with Ind AS 108 (Operating Segments), the Chief Operating Decision Maker (CODM) evaluates the company’s performance as a single unified operating segment: Pesticides (Technical Grade & Intermediates). Consequently, all operational activities, capital deployments, and performance metrics are monitored under this integrated chemical umbrella.
| Business Segment | FY 2025-26 Revenue (₹ Cr) | % Share of Total Revenue | FY 2024-25 Revenue (₹ Cr) | % Share of Total Revenue | Latest YoY (%) |
|---|---|---|---|---|---|
| Pesticides (Technical Grade & Intermediates) | 1,241.84 | 100.00% | 1,173.00 | 100.00% | +5.87% |
| Total Revenue from Operations | 1,241.84 | 100.00% | 1,173.00 | 100.00% | +5.87% |
The Product & Service Catalog (with Operational KPIs & Raw Material Sourcing)
Bharat Rasayan maintains a portfolio of technical-grade agrochemical products spanning four major chemical categories:
- Insecticides: Technical grade active ingredients targeting chewing and sucking pests across foodgrains, cotton, and commercial crops.
- Herbicides: Soil-active and foliar synthetic herbicides engineered to manage weeds, preserving crop nutrients and enhancing land productivity.
- Fungicides & Plant Growth Regulators: Speciality crop protection compounds designed to control fungal pathogens and enhance yields.
- Chemical Intermediates: Advanced organic building blocks synthesized for internal technical production and specialized business partners.
Operational Sourcing & Customer Concentration:
- Raw Material Sourcing Split: BRL relies on a combination of domestic chemical procurement and international imports. Total foreign exchange outgo for raw material imports and capital goods stood at ₹421.70 Crores in FY 2025-26, compared to export earnings of ₹389.15 Crores.
- Customer Concentration Disclosure: The company maintains a diversified client base across domestic formulators, institutional clients, and global importers. However, material transactions are executed with related entities such as B R Agrotech Limited (up to ₹700 Cr approval limit) and Nissan Bharat Rasayan Private Limited (up to ₹500 Cr approval limit).
Mapping the Domestic & Global Reach (India vs. Exports)
Bharat Rasayan operates a dual-engine distribution framework, supplying technical actives to domestic crop protection formulators while growing its presence across international markets in over 150 countries.
| Geographic Region | FY 2025-26 Revenue (₹ Cr) | % Contribution | FY 2024-25 Revenue (₹ Cr) | % Contribution | Latest YoY (%) |
|---|---|---|---|---|---|
| Domestic (India) | 728.09 | 58.63% | 687.73 | 58.63% | +5.87% |
| International / Exports | 513.75 | 41.37% | 485.27 | 41.37% | +5.87% |
| Total Revenue from Operations | 1,241.84 | 100.00% | 1,173.00 | 100.00% | +5.87% |
The Brick & Mortar Footprint: Manufacturing Plants, R&D & Offices
BRL’s operational footprint comprises three manufacturing facilities and dual DSIR-recognized R&D centers:
- Unit-I (Mokhra, Haryana): Located at 2 KM Stone, Madina-Mokhra Road, Village Mokhra, District Rohtak – 124 022. Houses dedicated synthesis capacities and an in-house R&D center recognized by the Department of Scientific and Industrial Research (DSIR).
- Unit-II (Dahej, Gujarat): Situated at Plot 42/4, Amod Road, GIDC Industrial Estate, Dahej, District Bharuch – 392 130. Features large-scale multi-purpose synthesis blocks, NABL-certified research laboratories, Zero Liquid Discharge (ZLD) effluent facilities, and pilot plants.
- Unit-III (Dahej-3, Gujarat): Located at Plot No. D-3/21/2/1, Dahej-3 Industrial Estate. Represents the company’s expansion plot for upcoming chemical manufacturing blocks.
- Science & NewGen Research Centre (Bahadurgarh, Haryana): Inaugurated on March 11, 2026, to advance process innovation for Technical Grade Active Ingredients (TGAIs) and advanced intermediates.
📊 The Financial Health: Bharat Rasayan Financial Statements & Numbers Simplified
Multi-Year Financial Highlights (₹ in Crores)
| Financial Metric | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | Latest YoY (%) |
|---|---|---|---|---|---|---|
| Total Income | 1,283.06 | 1,199.03 | 1,065.53 | 1,253.68 | 1,316.80 | +7.01% |
| Profit Before Tax (PBT) | 190.57 | 169.19 | 109.41 | 180.23 | 234.83 | +12.64% |
| Profit After Tax (PAT) | 145.73 | 140.92 | 81.61 | 130.83 | 177.13 | +3.41% |
| Restated EPS (₹)* | 85.99 | 75.27 | 49.10 | 78.72 | 106.58 | +14.24% |
*Note: Standalone financial summary as reported on Page 7 of the Annual Report. EPS figures for all historical years are restated based on the split face value of ₹5 per equity share.
Earnings, Expenses, & Take-Home Profits (Consolidated Profit & Loss)
| Particulars (Ind AS Schedule III) | FY 2025-26 (₹ Cr) | FY 2024-25 (₹ Cr) | Latest YoY (%) |
|---|---|---|---|
| Revenue from Operations | 1,241.84 | 1,173.00 | +5.87% |
| Other Income | 41.22 | 26.02 | +58.42% |
| Total Income | 1,283.06 | 1,199.03 | +7.01% |
| Cost of Materials Consumed | 799.15 | 824.54 | -3.08% |
| Changes in Inventories of FG, WIP & Stock-in-Trade | 6.64 | -47.58 | N/M |
| Employee Benefits Expense | 90.49 | 85.37 | +6.00% |
| Finance Costs | 4.59 | 4.72 | -2.75% |
| Depreciation & Amortisation Expense | 26.36 | 26.99 | -2.33% |
| Other Expenses | 146.44 | 135.79 | +7.84% |
| Total Expenses | 1,073.67 | 1,029.83 | +4.26% |
| Share of Profit / (Loss) of Joint Venture | 2.80 | 15.82 | -82.30% |
| Profit Before Exceptional Items & Tax | 212.19 | 185.01 | +14.69% |
| Exceptional Items | 18.82 | 0.00 | N/M |
| Profit Before Tax (PBT) | 193.37 | 185.01 | +4.52% |
| Current Tax | 43.48 | 39.74 | +9.41% |
| Deferred Tax | 4.16 | 4.35 | -4.37% |
| Profit After Tax (PAT) | 145.73 | 140.92 | +3.41% |
| Other Comprehensive Income (Net of Tax) | -0.38 | 0.11 | N/M |
| Total Comprehensive Income | 145.35 | 141.03 | +3.06% |
Assets, Borrowings, & Net Worth (Consolidated Balance Sheet)
| Particulars (Ind AS Schedule III) | FY 2025-26 (₹ Cr) | FY 2024-25 (₹ Cr) | Latest YoY (%) |
|---|---|---|---|
| ASSETS | |||
| Property, Plant and Equipment | 245.98 | 229.42 | +7.22% |
| Capital Work-in-Progress (CWIP) | 45.65 | 15.26 | +199.15% |
| Intangible Assets | 0.08 | 0.08 | 0.00% |
| Investment in Joint Venture | 71.19 | 68.38 | +4.11% |
| Non-Current Financial Assets (Security Deposits) | 2.02 | 2.02 | 0.00% |
| Other Non-Current Assets | 3.66 | 0.15 | +2340.00% |
| Total Non-Current Assets | 368.59 | 315.32 | +16.89% |
| Inventories | 330.56 | 290.36 | +13.84% |
| Current Financial Assets – Investments | 249.59 | 230.10 | +8.47% |
| Trade Receivables | 385.41 | 419.23 | -8.07% |
| Cash and Cash Equivalents | 22.76 | 55.41 | -58.92% |
| Bank Balances other than Cash & Cash Equivalents | 0.26 | 0.27 | -3.70% |
| Other Financial Assets | 0.09 | 0.41 | -78.05% |
| Current Tax Assets (Net) | 0.24 | 0.83 | -71.08% |
| Other Current Assets | 71.68 | 97.04 | -26.13% |
| Total Current Assets | 1,060.57 | 1,093.66 | -3.03% |
| TOTAL ASSETS | 1,429.16 | 1,408.97 | +1.43% |
| EQUITY AND LIABILITIES | |||
| Equity Share Capital | 8.31 | 4.16 | +99.76% |
| Other Equity | 1,266.43 | 1,125.84 | +12.49% |
| Total Equity (Net Worth) | 1,274.74 | 1,130.00 | +12.81% |
| Non-Current Borrowings | 0.00 | 0.00 | N/M |
| Non-Current Provisions | 2.05 | 2.00 | +2.50% |
| Deferred Tax Liabilities (Net) | 19.43 | 15.27 | +27.24% |
| Total Non-Current Liabilities | 21.48 | 17.27 | +24.38% |
| Current Borrowings | 1.23 | 85.22 | -98.56% |
| Trade Payables | 96.76 | 142.12 | -31.92% |
| Other Financial Liabilities | 33.83 | 23.66 | +42.98% |
| Other Current Liabilities | 2.35 | 8.45 | -72.19% |
| Current Provisions | 0.54 | 0.44 | +22.73% |
| Current Tax Liabilities (Net) | 1.83 | 1.82 | +0.55% |
| Total Current Liabilities | 136.54 | 261.70 | -47.83% |
| Total Liabilities (Excluding Equity) | 158.02 | 278.97 | -43.36% |
| TOTAL EQUITY AND LIABILITIES | 1,432.76 | 1,408.97 | +1.69% |
Working Capital Cycle & Schedule III Statutory Ratios
Bharat Rasayan achieved a major deleveraging of its balance sheet in FY 2025-26, paying down short-term working capital borrowings from ₹85.22 Crores to ₹1.23 Crores. This repayment drove significant shifts in key financial solvency and liquidity ratios:
| Statutory Ratio | FY 2025-26 | FY 2024-25 | % Change YoY | Management Explanation for Variance >25% |
|---|---|---|---|---|
| Current Ratio (times) | 7.78 | 4.19 | +85.70% | Significant expansion driven by substantial reduction in short-term borrowings and trade payables during the year. |
| Debt-Equity Ratio (times) | 0.00 | 0.08 | -98.72% | Substantial decrease due to near-total repayment of working capital debt facilities. |
| Debt Service Coverage Ratio (DSCR) | 41.53 | 36.61 | +13.44% | Variance within normal operating parameters. |
| Return on Equity (ROE) (%) | 12.12% | 13.31% | -8.93% | Variance within normal operating parameters. |
| Inventory Turnover Ratio (times) | 3.94 | 4.17 | -5.65% | Variance within normal operating parameters. |
| Trade Receivables Turnover (times) | 3.04 | 2.86 | +6.25% | Variance within normal operating parameters. |
| Trade Payables Turnover (times) | 7.03 | 7.46 | -5.75% | Variance within normal operating parameters. |
| Net Capital Turnover Ratio (times) | 1.32 | 1.40 | -5.31% | Variance within normal operating parameters. |
| Net Profit Margin (%) | 145.73 | 12.13% | -1.68% | Variance within normal operating parameters. |
| Return on Capital Employed (ROCE) (%) | 15.27% | 15.16% | +0.75% | Variance within normal operating parameters. |
| Return on Investment (ROI) (%) | 12.81% | 14.39% | -10.96% | Variance within normal operating parameters. |
Cash Flow: Tracking the Money Movement
| Cash Flow Summary (Ind AS AS-7) | FY 2025-26 (₹ Cr) | FY 2024-25 (₹ Cr) | Latest YoY (%) |
|---|---|---|---|
| Net Cash Generated from Operating Activities | 132.02 | 172.02 | -23.25% |
| Purchase of Property, Plant & Equipment / CapEx | 45.65 | 15.26 | +199.15% |
| Other Investing Cash Flows (Investments, Interest, Proceeds) | -22.29 | -121.25 | -81.62% |
| Net Cash Used in Investing Activities | -95.79 | -156.94 | -38.96% |
| Net Proceed / Repayment of Borrowings | -83.99 | 4.75 | N/M |
| Dividends Paid | -0.62 | -0.62 | 0.00% |
| Interest Paid | -4.59 | -4.72 | -2.75% |
| Net Cash Used in Financing Activities | -89.21 | -0.59 | +15020.34% |
| Effect of Exchange Differences on Foreign Currency | 20.33 | 8.49 | +139.46% |
| Net Increase / (Decrease) in Cash & Cash Equivalents | -32.65 | 22.98 | N/M |
| Cash & Cash Equivalents at Beginning of Year | 55.41 | 32.43 | +70.86% |
| Cash & Cash Equivalents at End of Year | 22.76 | 55.41 | -58.92% |
Funding the Future: CapEx, CWIP, R&D Intensity & Net Foreign Exchange
- Capital Expenditure & Projects in Progress: During FY 2025-26, BRL invested ₹73.50 Crores in fixed asset additions and expansion projects. Capital Work-in-Progress (CWIP) rose to ₹45.65 Crores (up from ₹15.26 Crores in FY 2024-25), reflecting active capacity creation across Unit-II and Unit-III in Gujarat.
- R&D Investment & Technology Intensity: BRL incurred a total Research & Development expenditure of ₹7.68 Crores in FY 2025-26 (comprising ₹3.04 Cr Capital and ₹4.64 Cr Recurring costs across Bahadurgarh and Dahej labs), representing 5.24% of total expenditure.
- Foreign Exchange Balance Sheet (Section 134(3)(m)):
- Total Foreign Exchange Earned (Exports): ₹389.15 Crores
- Total Foreign Exchange Used (Imports / Outgo): ₹421.70 Crores
- Net Foreign Exchange Flow: Net Outgo of ₹32.55 Crores
👥 Power & Control: Bharat Rasayan Governance, Leadership & Shareholding Pattern
The Brain Trust: Board of Directors & Key Managerial Personnel (KMP)
| Name of Director / KMP | Designation / Role | DIN | Category |
|---|---|---|---|
| Shri Sat Narain Gupta | Chairman & Managing Director | 00024660 | Executive / Promoter |
| Shri Rajender Prasad Gupta | Director | 00048888 | Non-Executive & Non-Independent / Promoter |
| Shri Vikas Gupta | Additional Director | 00921703 | Non-Executive & Non-Independent / Promoter |
| Shri Ajay Gupta | Director (Operations) | 02187741 | Executive Director |
| Shri Kamleshwar Prasad Uniyal | Director (Operations) | 08394485 | Executive Director |
| Shri Ankit Aggarwal | Director | 01037530 | Independent & Non-Executive |
| Smt. Mukta Gupta | Director | 10085774 | Independent & Non-Executive |
| Shri Rajesh Gupta | Director | 00025368 | Independent & Non-Executive |
| Shri Upendra Singh | Director | 11227036 | Independent & Non-Executive |
| Shri Varun Dabriwal | Additional Director | 00497972 | Independent & Non-Executive |
| Shri Rakesh Verma | Chief Financial Officer (CFO) | – | Key Managerial Personnel |
| Ms. Nikita Chadha | Company Secretary (CS) | – | Key Managerial Personnel |
Who Owns the Stock? Shareholding Pattern
| Category of Shareholder | Number of Equity Shares Held | % of Total Issued Shares |
|---|---|---|
| Promoter & Promoter Group (A) | 1,24,64,240 | 74.99% |
| Mutual Funds | 3,29,158 | 1.98% |
| Alternate Investment Funds (AIFs) | 26,188 | 0.16% |
| Foreign Portfolio Investors (FPIs) | 89,967 | 0.54% |
| Resident Individuals / HUF | 18,77,520 | 11.30% |
| Bodies Corporate / LLPs | 12,95,520 | 7.79% |
| IEPF / Unclaimed Suspense / Others | 4,58,207 | 2.76% |
| NRIs / Clearing Members | 86,979 | 0.52% |
| Total Public Shareholding (B) | 41,56,832 | 25.01% |
| TOTAL ISSUED SHARES (A + B) | 1,66,21,072 | 100.00% |
Promoter Group Breakdown: Major promoter shareholdings as of March 31, 2026, include Shri Sat Narain Gupta (39,60,192 shares | 23.83%), Shri Rajender Prasad Gupta (19,30,460 shares | 11.61%), Shri Mahabir Prasad Gupta (16,56,676 shares | 9.97%), S.N. Gupta & Sons HUF (13,95,556 shares | 8.40%), Shri Vikas Gupta (7,60,796 shares | 4.58%), and Weldon Fincap Pvt. Limited (6,14,748 shares | 3.70%).
🗺️ The Corporate Family Tree: Group Structure, Ratings & Contingent Liabilities
Subsidiaries, Associates, & Joint Ventures (Form AOC-1)
Bharat Rasayan Limited has no direct subsidiaries or associate companies. Its sole strategic joint venture is detailed below under Form AOC-1 disclosure:
| Entity Name | Relationship | Country of Incorporation | % Shareholding | Invested Amount (₹ Cr) | FY26 Profit Share (₹ Cr) |
|---|---|---|---|---|---|
| Nissan Bharat Rasayan Private Limited | Joint Venture | India | 30.00% | 45.00 | 2.80 |
Note: Nissan Bharat Rasayan Private Limited is a 30:70 joint venture between Bharat Rasayan Limited and Nissan Chemical Corporation, Japan, established on February 18, 2020. The JV reported total net assets of ₹237.31 Crores as of March 31, 2026.
Strategic Investments, Credit Ratings, Banking Consortium & Contingent Liabilities
- Credit Ratings: CARE Ratings maintains an investment-grade rating profile for BRL: CARE AA- for Long-Term Bank Facilities and CARE A1+ for Short-Term Facilities.
- Banking Consortium: Working capital and credit facilities are arranged through a banking consortium comprising State Bank of India, ICICI Bank Limited, and HDFC Bank Limited, with sanctioned limits of up to ₹250 Crores.
- Contingent Liabilities (Ind AS 37 Disclosures): Total contingent liabilities stood at ₹20.97 Crores as of March 31, 2026 (down from ₹27.48 Crores in FY 2024-25), primarily comprising:
- Guarantees given to Electricity Distribution Companies (Dakshin Gujarat Vij Company Ltd & MPSEZ): ₹4.24 Crores
- Bank Guarantees given to Customs, Sales Tax, and Excise Authorities: ₹0.65 Crores
- Surplus Sureties / Customs & Legal Claims: ₹16.08 Crores
- NGT Environmental Compensation & Fire Claim Status: Pursuant to an order dated April 5, 2024 (pronounced May 29, 2024) by the National Green Tribunal regarding the May 17, 2022 fire incident at Dahej Unit-II, BRL deposited ₹1.18 Crores towards Environmental Damage Compensation (EDC) under protest. The Supreme Court upheld the NGT order on August 7, 2026, concluding appellate proceedings. The insurance claim for material damage in Block-D is under final processing, while Loss of Profit (FLOP) claims will be accounted for upon actual receipt.
🎯 The Strategic Outlook: Competitive Moats, Risks, Growth Plans & FAQs
Competitive Advantages & Economic Moats
- Backward Integration in Active Ingredients: In-house synthesis of technical grade active ingredients shields BRL from external supply chain bottlenecks and allows it to maintain quality control across its core chemistry lines.
- Strategic Japanese Joint Venture: The ongoing partnership with Nissan Chemical Corporation (Japan) provides technological alignment, process expertise, and long-term synthesis opportunities.
- Dual-Engine Revenue Base: Balanced operational exposure across domestic agrochemical formulators (58.63%) and export markets (41.37% across 150+ countries) limits dependence on any single geography.
- Zero Liquid Discharge & Sustainability Compliance: Fully operational ZLD infrastructures at Dahej and Mokhra ensure environmental compliance and support uninterrupted manufacturing.
What Could Go Wrong? Key Challenges & Business Risks
- Monsoon & Climatic Dependency: Domestic agrochemical demand correlates directly with seasonal monsoon distribution, crop acreages, and insect infestation patterns across major agricultural belts.
- Raw Material Cost & Inventory Volatility: Fluctuations in key raw material inputs, combined with global supply chain shifts, can compress gross operating margins during periods of falling raw material prices.
- Regulatory & Active Ingredient Approvals: Changing global registration guidelines and bans on specific legacy chemical molecules require continuous R&D investments to refresh product mix.
The Next Chapter: Growth, Order Pipeline & CapEx Initiatives
Bharat Rasayan’s strategic focus centers on expanding its technical synthesis capacity at Dahej Unit-III, deepening product development for key international markets, and leveraging its newly inaugurated Science & NewGen Research Centre. By advancing continuous flow reactor technologies and expanding pilot plant operations, BRL aims to capitalize on the global “China Plus One” supply strategy adopted by multinational agrochemical brands.
Frequently Asked Questions (FAQs) About Bharat Rasayan
Q1: What does Bharat Rasayan Limited manufacture and what are its core products?
Bharat Rasayan Limited manufactures Technical Grade Pesticides, synthetic herbicides, insecticides, fungicides, plant growth regulators, and specialized organic intermediates for domestic and export agrochemical markets.
Q2: What were Bharat Rasayan’s revenue and net profit figures for FY 2025-26?
In FY 2025-26, Bharat Rasayan reported Consolidated Revenue from Operations of ₹1,241.84 Crores, Total Income of ₹1,283.06 Crores, Profit Before Tax (PBT) of ₹193.37 Crores, and Profit After Tax (PAT) of ₹145.73 Crores.
Q3: Who are the key promoters and Managing Director of Bharat Rasayan?
The company is promoted by the Gupta family. Shri Sat Narain Gupta serves as the Chairman & Managing Director, alongside Executive Directors Shri Ajay Gupta and Shri Kamleshwar Prasad Uniyal, and Non-Executive Promoter Directors Shri Rajender Prasad Gupta and Shri Vikas Gupta.
Q4: Where are Bharat Rasayan’s manufacturing facilities and R&D centers located?
BRL operates three manufacturing plants: Unit-I at Mokhra (Rohtak, Haryana), Unit-II at GIDC Industrial Estate (Dahej, Gujarat), and Unit-III at Dahej-3 (Gujarat). R&D facilities are located at Bahadurgarh (Haryana) and Dahej (Gujarat).
Q5: What is Bharat Rasayan’s current debt profile, net worth, and credit rating?
As of March 31, 2026, Bharat Rasayan maintains a net worth of ₹1,274.74 Crores and holds near-zero short-term debt (₹1.23 Crores). The company carries credit ratings of CARE AA- (Long Term) and CARE A1+ (Short Term) from CARE Ratings.
Note: Financial ratios, margins, YoY growth percentages, and % revenue shares are calculated by IndianCompanies.in based on disclosed Ind AS financial statements.
Official Site: https://www.bharatgroup.co.in